Comment from Physicians for Reproductive Health

Summary: Physicians for Reproductive Health, a physician-led national advocacy organization, supports the citizen petitions requesting the FDA eliminate restrictions on mifepristone access. They argue that mifepristone is safe and effective for medication abortion and miscarriage management, and that current restrictions—particularly those requiring in-person dispensing—unnecessarily create barriers to care and harm the patient-provider relationship.